glp 1 agonists for type 2 diabetes Targeting GLP-1, GIP & GCG in Obesity and Research Trends in the Development of

Injection site reactions occur in 14% of users, typically presenting as mild redness, itching, or temporary discomfort at the injection location

M6: \(\beta\)= 0.53, 0.66, 0.41

Anti-inflammatory effects of GLP-1 analogues GLP-1RAs exert their effects by activating the GLP-1 receptor (GLP-1R), a G protein-coupled receptor primarily associated with Gs and, to a lesser extent, Gq protein signaling

Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made

Physiological reviews, 87(4), 14091439

10.1016/j.euroneuro.2024.02.003 52 HaldenT